文献速递重症综合管理与镇静镇痛

盲法缺失与重症监护随机对照试验死亡结果之间的关联:一项元流行病学研究

Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论重症监护RCT中,非盲法试验的死亡效应估计值略大于盲法试验(合并比值比0.91;95%CI 0.84-0.99),但不能排除混杂。

该元流行病学研究纳入2009年1月至2019年3月发表于高影响因子综合医学或重症监护期刊及Cochrane的系统评价和Meta分析中的36项Meta分析、共467项随机对照试验,比较盲法与非盲法试验对死亡干预效应估计的差异。267项(57%)为盲法,200项(43%)为非盲法。非盲法试验的干预效应估计值显著大于盲法试验(合并比值比0.91;95%CI 0.84-0.99),各Meta分析间无异质性(p=0.72;I2=0%;τ2=0),调整偏倚风险条目的敏感性分析结果一致。作者认为在重症监护试验中应尽可能对患者和人员实施盲法,即使评价死亡结局时也是如此,但混杂不能排除。

要点

  • 36项Meta分析共467项RCT中,267项(57%)为盲法,200项(43%)为非盲法。
  • 非盲法试验的死亡干预效应估计值显著大于盲法试验(合并比值比0.91;95%CI 0.84-0.99)。
  • 各Meta分析间无异质性(p=0.72;I2=0%;τ2=0),调整偏倚风险条目的敏感性分析结果一致。
  • 作者认为在重症监护试验中应尽可能对患者和人员实施盲法,即使评价死亡结局时也是如此,但混杂不能排除。

适用人群与场景

  • 2009年1月至2019年3月发表于高影响因子综合医学或重症监护期刊及Cochrane的系统评价和Meta分析中,评价治疗性干预对重症监护患者死亡影响的随机对照试验。

诊断标准与关键阈值

  • 盲法试验定义为双盲和/或报告了充分的方法;非盲法试验定义为开放标签、单盲或盲法不明确。

研究设计与关键结果

  • 研究类型为元流行病学研究,纳入36项Meta分析中的467项随机对照试验,其中267项(57%)为盲法,200项(43%)为非盲法。
  • 非盲法试验的干预效应估计值显著大于盲法试验(合并比值比0.91;95%CI 0.84-0.99)。
  • 各Meta分析间无异质性(p=0.72;I2=0%;τ2=0)。
  • 调整偏倚风险条目的敏感性分析结果与主要分析一致。

证据类型、等级与局限

  • 证据类型为元流行病学研究。
  • 局限:混杂不能排除。

对床旁实践的改变

  • 作者认为在重症监护试验中应尽可能对患者和人员实施盲法,即使评价死亡结局时也是如此。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To investigate whether intervention effect estimates for mortality differ between blinded and nonblinded randomized controlled trials conducted in critical care. We used a meta-epidemiological approach, comparing effect estimates between blinded and nonblinded randomized controlled trials for the same research question.

DATA SOURCES: Systematic reviews and meta-analyses of randomized controlled trials evaluating a therapeutic intervention on mortality in critical care, published between January 2009 and March 2019 in high impact factor general medical or critical care journals and by Cochrane.

DATA EXTRACTION: For each randomized controlled trial included in eligible meta-analyses, we evaluated whether the trial was blinded (i.e., double-blinded and/or reporting adequate methods) or not (i.e., open-label, single-blinded, or unclear). We collected risk of bias evaluated by the review authors and extracted trial results.

DATA SYNTHESIS: Within each meta-analysis, we compared intervention effect estimates between blinded and nonblinded randomized controlled trials by using a ratio of odds ratio (< 1 indicates larger estimates in nonblinded than blinded randomized controlled trials). We then combined ratio of odds ratios across meta-analyses to obtain the average relative difference between nonblinded and blinded trials. Among 467 randomized controlled trials included in 36 meta-analyses, 267 (57%) were considered blinded and 200 (43%) nonblinded. Intervention effect estimates were statistically significantly larger in nonblinded than blinded trials (combined ratio of odds ratio, 0.91; 95% CI, 0.84-0.99). We found no heterogeneity across meta-analyses (p = 0.72; I2 = 0%; τ2 = 0). Sensitivity analyses adjusting the main analysis on risk of bias items yielded consistent results.

CONCLUSIONS: Intervention effect estimates of mortality were slightly larger in nonblinded than blinded randomized controlled trials conducted in critical care, but confounding cannot be excluded. Blinding of both patients and personnel is important to consider when possible in critical care trials, even when evaluating mortality.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Martin GL, Trioux T, Gaudry S, et al. Association Between Lack of Blinding and Mortality Results in Critical Care Randomized Controlled Trials: A Meta-Epidemiological Study. Crit Care Med. 2021. PMID: 33927122. doi:10.1097/CCM.0000000000005065

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。